Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26428 | 209 | 28.8 | 65% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 3012 | 2063 | CHRONOME//HALBERG CHRONOBIOL//CHRONOBIOLOGIA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FERTILITY CYCLE | Author keyword | 4 | 75% | 1% | 3 |
| 2 | CHRONOEPIDEMIOLOGY | Author keyword | 1 | 100% | 1% | 2 |
| 3 | SCREENING CAMPAIGNS | Author keyword | 1 | 50% | 1% | 2 |
| 4 | MENSTRUAL PHASE | Author keyword | 1 | 19% | 3% | 6 |
| 5 | BREAST UNITPROPEDEUT SURG 2 | Address | 1 | 50% | 0% | 1 |
| 6 | CERVICAL PREMALIGNANCY | Author keyword | 1 | 50% | 0% | 1 |
| 7 | ENDOCRINOL OUTPATIENT | Address | 1 | 50% | 0% | 1 |
| 8 | MENSTRUAL HORMONES | Author keyword | 1 | 50% | 0% | 1 |
| 9 | OESTROGEN REGULATED | Author keyword | 1 | 50% | 0% | 1 |
| 10 | UNOPPOSED ESTROGEN | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SURGICAL CURE | 8 | 28% | 12% | 26 |
| 2 | 5 YEAR ANALYSIS | 2 | 50% | 1% | 3 |
| 3 | PROGESTERONE RECEPTOR CONTENT | 1 | 15% | 2% | 4 |
| 4 | CIRCADIAN STAGE | 0 | 20% | 1% | 2 |
| 5 | INFLUENCES DURATION | 0 | 33% | 0% | 1 |
| 6 | LABORATORY VARIATION | 0 | 33% | 0% | 1 |
| 7 | METASTATIC TUMOR GROWTH | 0 | 14% | 1% | 2 |
| 8 | MAGNETIC FIELD DETECTION | 0 | 17% | 0% | 1 |
| 9 | ADJUVANT HORMONE THERAPY | 0 | 14% | 0% | 1 |
| 10 | FACTOR FGF RECEPTORS | 0 | 14% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Timing of breast cancer surgery in relation to the menstrual cycle - The rise and fall of a hypothesis | 2008 | 2 | 34 | 94% |
| Timing of surgery during the menstrual cycle and prognosis of breast cancer | 2000 | 10 | 36 | 67% |
| Menstrual timing of breast cancer surgery | 1998 | 30 | 53 | 47% |
| Timing of breast surgery in premenopausal breast cancer patients | 2011 | 0 | 27 | 70% |
| MENSTRUAL EFFECTS ON SURGICAL-TREATMENT FOR BREAST-CANCER | 1993 | 6 | 11 | 82% |
| Unopposed oestrogen and survival of breast cancer | 1998 | 5 | 57 | 32% |
| Models of breast cancer growth and investigations of adjuvant surgical oophorectomy | 2004 | 3 | 30 | 17% |
| Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments | 2001 | 6 | 20 | 20% |
| Perioperative stimulation of residual cancer cells promotes local and distant recurrence of breast cancer | 1997 | 15 | 98 | 9% |
| CIRCANNUAL VARIATIONS IN THE FREQUENCIES OF SOME DISEASES OF THE ORAL-MUCOSA | 1993 | 0 | 11 | 27% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BREAST UNITPROPEDEUT SURG 2 | 1 | 50% | 0.5% | 1 |
| 2 | ENDOCRINOL OUTPATIENT | 1 | 50% | 0.5% | 1 |
| 3 | WJB DORN VA MED | 1 | 29% | 1.0% | 2 |
| 4 | MED CHRONOBIOL | 1 | 18% | 1.4% | 3 |
| 5 | DORN MED CHRONOBIOL | 0 | 33% | 0.5% | 1 |
| 6 | FUNDAC TEJERINA | 0 | 33% | 0.5% | 1 |
| 7 | MOL NEUROBIOL CELL PHYSIOL | 0 | 25% | 0.5% | 1 |
| 8 | SERV COMPLEMENTARY MED ONCOL | 0 | 20% | 0.5% | 1 |
| 9 | CANC UK CLIN TRIALS STAT UNIT | 0 | 17% | 0.5% | 1 |
| 10 | WJB DORN VET AFFAIRS MED | 0 | 14% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000150109 | DORN VA MED//TUMOR DORMANCY//CONCOMITANT RESISTANCE |
| 2 | 0.0000141196 | FREUNDS ADJUVANT ARTHRITIS//CHRONOPHARMACOLOGY//CHRONOTOXICITY |
| 3 | 0.0000107385 | ER ICA//IMMUNOCYTOCHEMICAL ASSAY//PROGESTERONE RECEPTORS |
| 4 | 0.0000103070 | PLASMA VEGF//MANCHESTER RENAL GRP//PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR |
| 5 | 0.0000091581 | DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST |
| 6 | 0.0000084795 | CHRONONEUROENDOCRINE ONCOL//CIRCADIAN DISRUPTION//LIGHT AT NIGHT |
| 7 | 0.0000075025 | PERITUMORAL VASCULAR INVASION//BLOOD VESSEL INVASION//AXILLARY NODE STATUS |
| 8 | 0.0000074762 | CHRONOME//HALBERG CHRONOBIOL//CIRCASEPTAN |
| 9 | 0.0000067749 | CIRCADIAN RHYTHM OF HORMONES//HOSP DELTA//HEMORRHAGIC GASTRITIS |
| 10 | 0.0000065307 | PAPER CAPILLARY PERMEATION ADSORPTION//SEPARATABILITY//APRC |